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Integrated surveillance systems for antimicrobial use (AMU) and antimicrobial resistance
(AMR) require regular evaluation to ensure the effectiveness and efficiency of the system.
An important step in the evaluation is to choose an appropriate tool for the purpose of
the evaluation. The “Integrated Surveillance System Evaluation” (ISSE) framework is a
conceptual framework that was developed to evaluate One Health (OH) integration in
surveillance system for AMU/AMR. This study aimed to evaluate the performance and
value of integrated surveillance system for AMU/AMR in England by applying the ISSE
framework, which was used to develop data collection protocols and define the study
design. A qualitative study using semi-structured interviews was conducted to collect
the data and analyse it thematically. Eighteen stakeholders from human, animal, food
and environment sectors that are involved in AMU/AMR surveillance were interviewed.
Four main themes emerged from the analysis: (1) Cross-sectoral integration in the
surveillance system for AMU/AMR; (2) Production of OH outputs and outcomes; (3)
Drivers and barriers to cross-sectoral collaboration; and 4) Need for more cross-sectoral
collaboration. The findings showed that there were links between integrated surveillance
information, decision making and interventions. However, there were only few OH
examples, such as the UK AMR contingency plan, where the potential of cross-sectoral
collaboration was fully exploited. A lot of the benefits described were related to the
generation of information and increase in knowledge and understanding without links
to how the information generated was used. While these intangible benefits have a
value on their own, being able to link surveillance information and mitigation measures
would help to enhance the value of integrated surveillance. In terms of improvement,
the main areas identified were the development of more harmonised methods for data
collection and analysis, provision of resources dedicated to cross-sectoral collaboration,
improved coordination, and collection of surveillance data from the environment and from
companion animals. By identifying links between OH surveillance information produced
and various outputs and outcomes; this study helped to understand the wider benefits
of integrated surveillance for AMU/AMR in England and provided insights on how the
system could be improved and efficiency increased.
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INTRODUCTION
The worldwide recognition of the crisis caused by antimicrobial
resistance (AMR) has prompted international organisations to
call for all countries to develop national action plans (NAP) to
address this threat (1). Surveillance is an essential component of
any NAP and due to themultiple transmission pathways of AMR,
surveillance data need to be collected from humans, animals,
food and the environment in a coordinated and harmonised way
to allow cross-sectoral analyses (2). This integrated approach
to surveillance is also known as One Health (OH) surveillance
and has been promoted by international organisations (1). One
Health surveillance for AMU and AMR refers to surveillance
that is based on a systemic, cross-sectoral, multi-stakeholder
perspective to inform mitigation decisions with the aim to
keep antimicrobials effective for future generations.1 Integrated
surveillance across the different sectors for antimicrobial use
(AMU) and AMR allows a better understanding of the sources
of infections and the routes of transmission; therefore enhancing
our understanding of the epidemiology of AMR and informing
better evidence-based interventions. In addition, it allows to link
data on AMU and AMR, which would enable to identify if the
reduction of AMU is having the desired effects on AMR in both
humans and animal populations (2).
To ensure that the surveillance systems are operational,
efficient and cost-effective, regular evaluation is needed (3). Even
if the system is not built to follow OH surveillance principles,
evaluation from a OH perspective allows to assess whether cross-
sectoral collaboration generates added value (4). An important
step in the evaluation is to choose an appropriate tool for
evaluation to ensure that the outputs are reliable for stakeholders
and decision makers (5). To the knowledge of the authors,
only one framework exists that was developed specifically to
assess the integration of the surveillance system for AMU/AMR,
called the “Integrated Surveillance System Evaluation” (ISSE)
framework (4, 6). This framework was developed based on the
Canadian Integrated Program for AMR Surveillance (CIPARS)
and provides a conceptual basis for structuring the evaluation of
different surveillance outcomes.
Multiple tools and frameworks are available either for
the evaluation of surveillance (e.g., SurvTools developed in
the Risk-based Animal health Surveillance Systems-RISKSUR-
project, the Assessment Tool for Laboratories and AMR
Surveillance Systems-ATLASS) or One Health (e.g., the Network
for the Evaluation of One Health -NEOH tool). These tools
range in application from assessing laboratory capacity in
the surveillance system to the assessment of governance, but
none of them provides a focussed approach for the evaluation
of OH AMU/AMR surveillance. A recent study documented
the strengths and weaknesses of six evaluation tools namely,
SurvTools, NEOH, ISSE, ATLASS developed by the Food and
Agriculture Organization (FAO), the Progressive Management
Pathway tool on AMR (PMP-AMR) developed by the FAO,
and the Evaluation of Collaboration for Surveillance (ECoSur)
tool (7). These tools were applied to a range of case studies
1https://guidance.fp7-risksur.eu/.
conducted in eight countries. The authors found that the tools
covered aspects of AMU/AMR surveillance and OH to varying
degrees and they presented high degree of complementarity.
PMP-AMR, ATLASS, ECoSur and NEOH are evaluation tools
that provide a scoring system to obtain semi-quantitative results,
whereas ISSE and SurvTools would result in a plan for how
to conduct evaluation(s). The NEOH and ISSE were perceived
as the best tools for evaluation of OH aspects, and ECoSur as
best for evaluation of the quality of collaboration (7). Depending
on the evaluation questions, assessors will need to select a tool
that suits their needs (7). To guide users in choosing a suitable
evaluation tool, an international network of scientists developed
guidance for choosing an assessment approach from an inventory
of tools suitable for evaluating integrated AMU and AMR
surveillance systems in the project “Co-Eval-AMR–Convergence
in evaluation frameworks for integrated surveillance of AMU and
AMR.”1
In the UK, a five-year AMR strategy based on a One Health
approach was developed in 2013 and included actions relevant
to humans, animals and the wider environment. In 2019, a
nationwide OHNAPwas developed alongside a 20 year vision for
containing and controlling AMR by 2040 (8, 9). Surveillance is an
integral part of the NAP and the data collected include AMU data
from humans and animals and AMR data from humans, animals
and food (10). The surveillance system for AMU/AMR in the
UK is organised in each sector separately with presence of cross-
sectoral integrated activities (10). The aim of this study was to
evaluate qualitatively the performance and value of the integrated
surveillance system for AMU/AMR in England by applying the
ISSE framework. This framework was selected, because it is the
only one developed specifically to evaluate integration in the
surveillance system for AMU/AMR. The focus is on England
and not the whole UK because our previous mapping of the
surveillance system for AMU/AMR in the UK showed variations
in the surveillance system between the four UK nations (10).
To our knowledge this is the first evaluation of the AMU/AMR
surveillance in England from a OH perspective. Information
about the performance of the integrated surveillance system for
AMU/AMR can provide insights into what is working well in the
system, where are gaps and how the system can be improved and
efficiency increased.
METHODS
Conceptualisation of the Evaluation
The ISSE logic model for OH surveillance for AMU/AMR
was used as a basis to conceptualise the evaluation of the
integrated surveillance system for AMU/AMR in England and to
develop data collection protocols. It comprises of five evaluation
levels based on the hierarchy in the expected chain of events
that emerged from focus group discussions and workshops
organised with CIPARS team members (4, 6). The logic model
(Figure 1) illustrates the relationships between the different
integrated surveillance activities, outputs and the expected
outcomes and impact. A modification was made to the logic
model by adding a planning step to the surveillance activities.
The different levels of the evaluation target different aspects in
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FIGURE 1 | Logic model for a generic OH surveillance system for AMU/AMR including five evaluation levels. Adapted from Aenishaenslin et al. (4).
the system that include: (1) OH integration across the different
components of the surveillance system including data collection,
analysis and interpretation, and information dissemination; (2)
Production of OH information and expertise; (3) Generation of
actionable knowledge; (4) Influence on decision making; and (5)
Contribution to desirable outcomes.
Possible benefits of integrated surveillance depend on
the links between the information generated by integrated
activities and changes implemented to reduce AMR (e.g., an
intervention or new policy). In the ISSE framework, the value
of integrated surveillance for AMU/AMR was conceptualised
across immediate, intermediate and ultimate outcomes (4, 6).
Immediate outcomes include increased understanding of AMR
epidemiology from a OH perspective and early warning of
emerging resistance. Intermediate outcomes include changes in
policy or behaviours resulting from OH information generated,
and the expected value is in the size of the reduction in
AMU and AMR that results from these changes. Ultimate
outcomes include tangible benefits such as improved animal,
human and environmental health and associated socioeconomic
benefits (4, 6).
We also made use of two other evaluation tools to expand on
OH integration, namely the NEOH (11) and the ECoSur (12)
tools. The NEOH tool provides guidance for the evaluation of
OH initiatives including description of the context, the initiative,
its theory of change, identification of outcomes and assessment of
One Health-ness (i.e., the strength of OH). The latter is assessed
using six characteristics that include systemic thinking, holistic
planning, transdisciplinary working, OH sharing, OH learning,
and systemic organisation (11). The ECoSur tool provides
guidance on how to assess the organisation, functioning and
functionalities of collaboration taking place in a multi-sectoral
surveillance system (12).
Study Design
Qualitative interviews were conducted using a semi-structured
interview guide (Supplementary Material A) with open-ended
questions that enabled depth and flexibility in exploring
experiences, influences and opinions of respondents.
The guide was developed to capture data on (i) integrated
surveillance activities for AMU/AMR in England (the activity
was considered integrated if there was collaboration between
at least two of the following sectors: animal, human, food
and the environment), (ii) links between surveillance activities
and outputs, (iii) links between outputs and outcomes,
(iv) the impact of surveillance information on decision
making, (v) the impacts of the decisions attributable to
integrated activities, (vi) data and information sharing, (vii)
need for improvement. Questions (i) to (v) were developed
by the authors following the logic of the ISSE framework
to explore the links between the integrated surveillance
activities and the outputs and outcomes. To account for
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TABLE 1 | Grid for participants’ selection.
AMU and AMR surveillance in England
Humans Animals Food Environment
Policy and regulatory bodies
Public Health England (PHE) [3]
Veterinary Medicines Directorate
(VMD) [1]
Food Standards Agency (FSA) [3] Environment Agency (EA) [1]
Implementing bodies Animal and Plant Health Agency
(APHA) [3]
Other sectors/stakeholders - Animal industry: Responsible Use of Medicines in Agriculture Alliance (RUMA) [1]
- Small animal sub-sector*: VetCompass [1], Small Animal Veterinary Surveillance Network (SAVSNET) [1]
- Academia/Research: Bristol University [1], Quadrum Institute [1]
- Veterinary body: British Veterinary Association (BVA) [1]
- Others: Cornwall One Health AMR group [1]
The number of participants from each organisation is included between brackets. *These participants were from Academia and were interviewed because of their expertise in VetCompass
and SAVSNET.
data on OH sharing [questions (vi)], questions related to the
evaluation of data and information sharing were included
based on protocols from the NEOH framework (11). Because
effective coordination underpins all surveillance activities,
questions related to the steering and coordination of integrated
surveillance activities were added to questions (i) based on the
ECoSur tool (12).
Data Collection
In a previous study to characterise and map the surveillance
system for AMU/AMR in the UK, a list of key organisations
involved in the national surveillance system for AMU/AMR
was developed (10). Interviewees were purposefully selected
from this list and also using snowball sampling (i.e., participant
referrals of other participants). The key informants were selected
because they had knowledge and expertise on AMU/AMR
surveillance in England and were directly involved in the
surveillance system. Selecting participants who were able to
provide rich and in depth information about the questions
researched was critical for the study. Participants included
representatives from regulatory bodies, implementing bodies and
other stakeholders from human, animal, food and environment
sectors. The list of these organisations is presented in Table 1
with the number of participants from each organisation included
in brackets. Information about the roles of participants is
included in Supplementary Material B. Two pilot interviews
were conducted to test the interview guide. Unclear questions
were modified accordingly based on the feedback provided. The
interviews were conducted by HB between May and December
2019 (eleven in person, three by phone and four by skype)
and lasted for up to 60min. An information sheet with the
description of the project and the objectives of the interview
were sent to participants prior to the meeting and they had the
possibility to clarify any questions before the interview. Written
consent for participation in the interview and audio recording
was obtained from participants before the interview. Interviews
were recorded with a digital device (Olympus WS-853 MP3
digital stereo voice recorder). The findings were anonymised
to protect the identity of informants and participants were
coded as “Pn,” where n ranged from 1 to 18. The interviews
broadly followed the topic guide and although the topics
were common across interviews, the order and emphasis on
different themes varied to focus on the issues most relevant for
each participant.
This study received ethical approval from the Social Sciences
Research Ethical Review Board (SSRERB) at the Royal Veterinary
College, with the approval number URN SR2019-0204.
Analysis
All interviews were recorded and transcribed verbatim by
a professional company. Transcripts were transferred into
NVivo12 Plus (QSR International Pty Ltd) for data management
and analysis. A thematic analysis was used in this study,
which is a method for identifying, analysing and reporting
patterns (themes) within the data (13). A combined approach
to the analysis was used enabling themes and subthemes
to be developed both deductively from the logic model
and the interview topic guides and inductively from the
experiences and views of participants. Initially, four transcripts
were analysed by the first author and codes were generated.
Then, a meeting with a second researcher in the team
(BH) was organised to review the emerging codes and
discuss the interpretation of the findings. Following this
discussion, the coding frame was updated and then applied
iteratively to the transcripts, refined and reapplied until no
new codes were generated. Key themes identified are used as
headings to organise the findings and summarised thematic
information from all participants were included and the most
illustrative quotes from the interviews were used to highlight
critical points.
RESULTS
In the following sections, the key themes identified are
presented, namely (1) cross-sectoral integration in the
surveillance system for AMU/AMR, (2) production of OH
outputs and outcomes, (3) drivers and barriers to cross-
sectoral collaboration, and (4) the need for more cross-sectoral
collaboration. An overview of the themes and subthemes is
presented in Figure 2.
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FIGURE 2 | Overview of themes (circles) and subthemes (rectangles) developed during the analysis of the interviews with 18 stakeholders.
TABLE 2 | Integrated surveillance activities.
Integrated activity Description
AMR contingency plan or Res-Alert Refers to the response upon identification of a resistant bacterial isolate from an animal
considered to pose a potential risk to human and/or animal health. It is a UK wide initiative
initiated in 2015 and coordinated by the VMD in collaboration with government agencies
covering human, animal, food and the environment, and the Devolved Administrations.
UK OH report on antibiotic use and resistance Produced by PHE and the VMD. Published for the first time in 2015 with and a second report
published in 2019 (14, 15).
Advisory committees in one sector with representatives from other
sectors
Examples of these committees include the DEFRA antimicrobial resistance coordination
(DARC) group; the Advisory Committee on Antimicrobial Prescribing, Resistance and
Healthcare Associated Infection (APRHAI); and the Advisory Committee on Microbiological
Safety of Food (ACMSF) subgroup on AMR;
The Responsible Use of Medicines in Agriculture Alliance (RUMA)
Target Task Force (TTF)
This group was formed in 2016 to develop specific targets for the key UK livestock sectors.
The group comprises mainly stakeholders from the animal health sector representing the
government and industry, with only one representative from the food sector which is the FSA.
In addition, an independent scientific group was formed with experts from animal and human
sectors to provide advice to the TTF group.
Cross-Sectoral Integration in the
Surveillance System for Antimicrobial Use
and Antimicrobial Resistance
Integrated surveillance activities reported by interviewees are
described below, in addition to the following sub-themes
identified: data and information sharing, coordination of
cross-sectoral collaboration; resources; global and regional
collaboration; and the link between surveillance and research.
Integrated Surveillance Activities
Various cross-sectoral surveillance activities were reported by
the interviewees and several of them are UK wide, even though
the evaluation focused on England. Key integrated activities
are presented in Table 2 and more detailed descriptions of
these activities can be found in (Supplementary Material C).
Examples of other integrated surveillance activities reported
by participants include collaboration between the two main
government (PHE and APHA) laboratories to exchange
information about cases and compare isolates, joint conferences,
and collaboration between APHA and the British Society for
Antimicrobial Chemotherapy (BSAC).
Data and Information Sharing
In England, there is no annual joint surveillance report for
AMU/AMR but there are annual surveillance reports published
separately by human, animal and food sectors that are publicly
available online (16–18). For animals, these data are published
aggregated for the UK in the Veterinary Antimicrobial Resistance
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Surveillance (VARSS) reports. In humans, there is the English
Surveillance Programme for Antimicrobial Use and Resistance
(ESPAUR) report for England. Also, indicators for AMU and
AMR are publicly accessible in the “Fingertips” data portal2
which contains data on a range of public health issues categorised
as “profiles;” one of them is “AMR Local Indicators.” For AMR
in food (at retail level and from processing plants), results of
the EU harmonised surveillance and reports of ad-hoc surveys
conducted are published in the FSA webpage (10).
Although there is no structured mechanism for data and
information sharing between sectors, respondents explained that
a lot of the data generated are available in these public domains
and accessible to all. Some of the data are also published in
scientific publications and respondents highlighted that some
sensitive data cannot be shared such as those related to the
farms. The benefits of making the data widely available was also
emphasised: “Our overarching policy is to share as much data
as possible, because the more people who have access to it the
more other researchers can benefit and possibly find a solution
for us” (P6).
In addition to the data that are publically available, one
respondent mentioned that if some other data are needed, they
could be requested and obtained: “You mean requested or really
have it? We could request it . . . There are lines of communication,
but not on a routine basis” (P10). There are also situations where
certain agreements are made to share information depending on
the project: “. . . you have a lot of work going on in terms of research,
for example, and as part of those research projects probably they
have agreements to share data specifically for a particular pathogen
or particular organism that they are looking at. . . Other than that,
as part of Res-Alert I think it would be expected that sharing is kind
of agreed” (P1).
Coordination of Cross-Sectoral Activities for
AMU/AMR Surveillance
The surveillance system for AMU/AMR is a key component of
the NAP for AMR and the recommendations from the NAP are
used as levers to implement collaborative surveillance activities.
The NAP is coordinated by an interdepartmental High Level
Steering Group (HLSG) which is dedicated to strategic decisions
at high policy level but there is not a committee in charge of the
coordination of integrated surveillance activities for AMU/AMR:
“. . . The national action plan is One Health. So the governance
of that is going to be One Health with representatives from across
the One Health spectrum. Then anything under that will still
be One Health” (P1). Although, there is a call in the NAP for
more coordination and harmonisation of surveillance schemes
across sectors, there is no clear guidance on how to organise
collaboration across institutions to achieve this (9). Respondents
explained that the different institutions need to define the
modalities to achieve the objectives of the NAP including the
organisation of cross-sectoral activities and that there are cross-
sectoral groups and committees where discussions about these
aspects take place: “While we deliver the NAP and the vision of
the NAP, everything is One Health, and from governance of the
2https://fingertips.phe.org.uk/profile/amr-local-indicators.
NAP, which at the moment we are in the process of developing as
a result of the new action plan. . . ., we have multi-sectorial groups
and committees, for example, where we all work together as part
of a cross-government One Health approach” (P1). Examples of
these groups include the different advisory committees in each
sector such as the DARC group, the APRHAI and the ACMSF
subgroup on AMR. Most participants mentioned the importance
of cross-sectoral collaboration on AMU/AMR surveillance to
tackle AMR and some mentioned the lack of coordination or
the need for improvement in coordination. These aspects are
explored in more depth in section Need for More Cross-Sectoral
Collaboration on AMU/AMR Surveillance.
Resources for Cross-Sectoral Collaboration
In terms of resources, respondents mentioned that there is no
fund available specifically for cross-sectoral collaboration and
that the budget available for surveillance needs to be used to cover
any integrated activities: “There is a budget for AMR surveillance
and that budget should cover any Res-Alert” (P1). In cases where
there are projects covering issues related to different sectors, then
there is a budget to look specifically at that particular issue like
for example in the case of ESBL: “So generally if there’s a cross
sectoral issue, so ESBL is probably quite a good one. So ESBL E-coli
in animals and men, so the Department of Health funded a study
that has looked at ESBL occurrence in humans and in sewage and
in farms in five regions of the UK” (P4). This sectoral allocation
of resources is due to how the sectors evolved historically into
segregated “silos” (19). This siloed funding has been discussed in
previous studies as a barrier to cross-sectoral collaboration (20,
21). Where cross-sectoral collaboration requires establishment of
new structures and processes (e.g., creation of a new One Health
unit or integrated database), a financial cost is involved. In the
absence of dedicated funding, cross-sectoral collaboration relies
on the use of existing infrastructure and in-kind contributions,
which limits its potential.
Global Collaboration and the Value of Collective Data
The UK contribution to European and international surveillance
programmes has been praised by respondents who highlighted
the importance of comparing data to other countries and
assessing them at global level, which add value to the data. The
following quote illustrate this: “. . . so within Europe, EFSA is the
regulatory body for the animal side and ECDC the humans, so they
do write joint reports, so all member states will submit to them and
they will write joint reports and that gives you an idea of what may
or may not be going through and the things that might be, so they
do a lot of work to look at it at that level, which is a higher level
than specific country levels” (P5). These collective data allow to
see the bigger picture, which enables to generate more knowledge
and information.
Due to the uncertainties around Brexit, participants expressed
concerns about the impacts that this could have on UK
contribution to European surveillance and stressed that it is
important that surveillance data from the UK are represented
in the European picture: “Final thing is obviously about data
going forward in Brexit. . . ..We would hope that data on AMR will
continue to be collated by EFSA and others so I think there is a
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challenge there to make sure that the UK surveillance data goes into
the international picture because we are part, we’re still in Europe
even if we’re not in the EU. And that data collectively is important.
. . . .We contribute our data to that but obviously we would feel, yes,
this data needs to be kept intact because once you start to fragment
it you’re going to lose this information” (P6). The EU implemented
additional AMR surveillance requirements from 2021,3 but as
these came into force post-transition period, the UK continues to
follow the previous protocols. The extent of future data-sharing
between the UK and the EU has not yet been agreed.
Regional Collaboration
One special type of collaboration that was identified was the
Cornwall OH Antimicrobial Resistance group (CARG). CARG
is the first regional OH group on AMR established in the UK
and was set up in 2014 to ensure the implementation of a
coordinated wide response to the AMR strategy in Cornwall
(22). The group has representation from different stakeholders
including doctors, veterinarians, microbiologists, nurses, dentists
and researchers. Various activities conducted were mentioned
including the organisation of OH AMR conferences in Cornwall
with attendance from different stakeholders, organisation of
educational sessions, and collaboration with veterinarians
(mainly those working with dairy farmers as this is the biggest
food producing sector in Cornwall) to collect and share antibiotic
usage data. This collaboration was considered to have been
successful the first year but then got very little interest from
veterinarians the following years. When asked about the reason
for this initiative being unsuccessful, P13 said: “A real barrier
to these groups being set up nationally is that there’s no funding
for them.”
Surveillance and Research
An important integrated activity that was mentioned by most
interviewees was the collaboration in research, with a respondent
suggesting that there is more of a OH approach in research.
Surveillance and research were seen to complement each other:
“Research underpins our surveillance because the methods we
develop for research is used for surveillance” (P5). An example
that was mentioned was about some techniques that might be
expensive, such as some molecular techniques, and cannot be
implemented at a large scale. In this case, a target population
can be identified through research and then surveillance data are
collected from this population. Research provides also evidence
that underpins AMR policy: “We don’t know yet in terms of
the development of resistance and how much of this is caused by
or starts in the environmental or animal sector, so there is still
room for, or there needs to be much more research to understand
this and where intervention would be most efficient or effective”
(P10). An emphasis was made to the difference between the
research conducted by government laboratories or institutions
with links to policy makers and those conducted by academia
with the former having greater impact: “. . .because we’re working
in government, that link to government is much more direct than
3https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:
32020D1729&from=EN.
it is in academia. Academia does do a lot of research. . . .so it’s
helping to drive forward knowledge and understanding which will
eventually impact,. . . but maybe some of the time it may not be
as direct” (P5).
Production of One Health Outputs and
Outcomes
This section outlines the various outputs and outcomes of
OH surveillance activities that interviewees identified. These
include the detection of emerging resistance, provision of better
information for decisionmaking, behaviour changes, exchange of
information and expertise, learning from each other, increase of
awarness and understanding, better harmonisation, provision of
stronger messages and adding value to the data.
Detection of Emerging Resistance and Provision of
Enhanced Information for Risk Assessment Leading
to Better Risk Management and Decision Making
The AMR contingency plan (Res-Alert) allows to detect emerging
resistance and was considered as an effective and action oriented
activity: ”. . . it works really well I would say and it is really . . .
action and outcome orientated. They really get the right people . . . ”
(P10). When a hazard is detected, relevant advisory committees
are notified by the relevant agencies and meetings are organised
to discuss the risk assessment and decide on the options for
risk management and the plan for risk communication (14).
During these meetings, decisions are taken by the OH team to
generate the evidence needed to assess the risk of the particular
hazard. One of the cases mentioned that triggered a Res-Alert
was the discovery of mediated colistin resistance (mcr-1) in
a pig farm in England in 2015 (23). In this case, various
surveillance activities have been triggered in the different sectors
including testing archived samples in humans and animals.
The OH information collected was used to inform the multi-
sectoral discussions and assessments conducted as part of the
Res-Alert: “I think the colistin. . . . So that was one of the major
cases that we have had to deal with as part of Res-Alert. . . ..
Basically, after it was detected, we increased the surveillance, so
we decided to do targeted surveillance and look at samples that
were already stored in our archives to look back and see what
was the prevalence, or whether it had been there before. . . .So
yeah, there were certain decisions that were made to actually
generate the evidence that was needed to evaluate, to assess the
risk that we were dealing with. One of them was to look at
samples that were already available. To go to the farm where the
colistin resistance was detected and do further sampling, collect
data” (P1). The outcomes of the assessments were shared with
relevant stakeholders, which led to behaviour changes in farmers
and voluntary restrictions on colistin use in food producing
animals in the UK (14, 24). Public Health England declared
that the risk to human health was considered to be very low
and the FSA declared the risk to public health from food
to be very low when food was properly handled and cooked
(24). Because of timely risk assessment and data integration,
better information was available which allowed better informed
decisions to be taken.
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Better Harmonisation Between Sectors
There are variations in the methods used in the various
sectors and the work by the OH team producing the UK OH
reports on antibiotic use and resistance (OH information) was
seen as an opportunity for cross-sectoral discussions on ways
to align the data across sectors. These reports included also
recommendations to address data limitations and to improve
integrated analyses. The following quote illustrates this: “. . .we
were having regular meetings with VMD and then there was
DEFRA involved as well and so we were talking about it and
thinking forward how things could work together, so we do work
across sectors to try and get things to be aligned a bit better so that
we can make the report more useful to everyone” (P11). Another
respondent explained how the work on these reports helps to
improve the harmonisation of the methods used between sectors:
”. . . since the publication of the first report, we worked on trying
to harmonise more, so in the first report made recommendations
like for a more representative sample of campylobacter in the
human sector and we panel tested whether that could be more, be
standardised across the two sectors” (P10).
Exchange of Information and Expertise Leading to an
Increase in Awareness and Understanding, Learning
and Building Good Working Relationship
The DARC group was considered by respondents as a good
platform for exchange of information and expertise between
members of the OH team of DARC. DARC was also seen as
a forum to discuss any issues raising from a OH perspective
considering all the implications: “One of the things a DARCwould
do is look at that and discuss this is obviously a threat, a hazard,
to the UK, to the UK’s poultry production. We know it affects
humans. So if we get cases should we treat it? Should we try and
contain? Should we try and eradicate it? So the decision doesn’t
just go to DARC because there are some salmonella committees
as well, but then the decision can be discussed between us and
medical colleagues” (P4). Although DARC was not considered
to be a decision-making group, it was felt that if an important
issue was raised this would be followed up: “I think DARC is
mostly an advisory group so it’s not a decision making group,
although all the people who are involved in DARC have some sort
of decisional power over this subject. So clearly if it’s raised then
it’s agreed collectively that it would be good to do one thing or
the other then normally it gets followed up” (P2). Respondents
acknowledged that the various sectors have different objectives
and priorities but cross-sectoral communication was seen as key
to enable reaching realistic solutions: “I would say that each
sector takes the lead in its own area. I think it’s probably quite
understandable. . . .. So I would say a little bit of a delineation of
responsibilities but often the discussion helps in trying to formulate
what’s a realistic policy” (P4).
Another outcome of cross-sectoral collaboration that was
mentioned was the increase in understanding of how other
sectors work and the different issues they are dealing with;
learning from each other; and the establishment of good working
relationship across sectors: “It’s understanding really because
it’s something that I’m certainly not an expert in and knowing
that there are differences, getting a better understanding of how
antibiotics are used in the environment or in agriculture in
any way, which I think, I think that’s important because it’s
something that you feel very isolated when you’re looking at
hospitals primarily, . . . , to know about the different influences
outside and I think it’s really useful to have this collaboration
and knowledge. . . . And, it’s a good working relationship that you
build with other departments essentially” (P11). Several examples
about opportunities to learn from each other were mentioned by
respondents such as benchmarking antibiotic use in humans and
its impact on behaviour change in humans; it was suggested that
this is something that could be applied to the veterinary sector.
Benchmarking antibiotic use between pig farmers is possible
due to the electronic Medicine Book (eMB) launched in 2016,
which is a digital system to collect data on antibiotic use at
farm level (25). A new centralised database called the Medicine
Hub has also recently been launched for ruminants, which allows
producers to record their antibiotic usage data and it has also a
benchmarking facility (25).
Provision of Stronger Message and Evidence to
Inform Interventions
OH information generated by integrated surveillance activities
was seen to provide an understanding of the bigger OH picture
and to generate stronger evidence to inform interventions:
“So I think it kind of gives you a much more rounded
picture. . . . I suppose if you can show that you’ve considered
sort of all areas, the veterinary and the human aspects and
the environment, then it provides a sort of better evidence
base for any recommendations that you put in there” (P12).
Similarly, activities that were conducted in a collaborative way
were considered to provide more powerful messages: “One
of the key things with collaboration is that when you come
out with your recommendation, if it says the human side, the
veterinary side and the environmental side, everybody saying
the same thing, that is an overwhelmingly powerful message,
as opposed to the vets saying it or just a human saying it”
(P16). An example described by respondents were leaflets on
Livestock Associated Methicillin resistant Staphylococcus aureus
(LA-MRSA) produced collaboratively by different organisations
including VMD, APHA, FSA and PHE.4,5 These leaflets were
addressed to farmers and people working in abattoirs with
information about the steps they could take to reduce the risk of
infection: “As you can see in the leaflet, lots of people collaborated
in putting that together, so it’s been signed by different government
departments and different organisations” (P1).
Sharing surveillance data to be used by other stakeholders was
also seen as making them more powerful and adding value to
the data: “Well I think it makes it more powerful, I mean there’s
the factor of using this data in ways that may not be otherwise
utilised. I think that provides benefits for the surveillance data and
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RUMA’s Independent Scientific Group, which was formed
by experts from different sectors to provide sounder advice
to the group, was also mentioned: “We’ve built it because we
need to have expertise in every area of this very complex subject
and we then base all our actions and all our policies on sound
science” (P14). The RUMA’S TTF was considered as a successful
initiative with most of the targets set forecasted to be met by
2020. These targets were developed by the TTF and focused
not only on reduction in antibiotic use but also development
of improved data collection systems for antibiotic usage at farm
level, improved husbandry and biosecurity practises, and training
on stewardship for farmers and veterinarians (25, 26). In the
latest UK-VARSS report published in 2020, the data showed
that antibiotic sales in food-producing animals halved since 2014
and over the same period, the use of Highest-Priority Critically
Important Antibiotics (HP-CIAs) has reduced by 72% (27).
Drivers and Barriers to Cross-Sectoral
Collaboration on AMU/AMR Surveillance
Respondents identified two main drivers for cross-sectoral
collaboration on AMU/AMR surveillance. Firstly, there was a
recognition of the interconnectivity between humans, animals
and the environment on AMR and the need for collaborative
efforts to tackle it: “The different surveillance activities,. . . some
focus on humans, some focus on animals, and by integrating
those data, that’s really important, that’s where you got the power
from because AMR is something that can cross species borders,
bacterial species borders, across different environments. So, it’s
really important to consider it as a whole to understand where
it’s coming from” (P18). Secondly, the fact that this collaboration
was a recommendation of the NAP meant that the different
institutions had to implement it. A previous study that was
conducted to evaluate of the implementation of the UK AMR
strategy 2013–2018 found that the strategy has greatly improved
communication and collaboration between human and animal
health sectors (28). Interviewees highlighted also the synergies
between human and animal sectors when tackling AMR: “There’s
obviously solutions on the human side, and obviously solutions
on the animal side and they’re so intrinsically linked, so avoiding
infection in the first place. Development of diagnostic tools,
development of new medicines, you know, the language is very
similar, the problems are similar, the solutions can be similar, the
behaviour change aspect is very similar on both sides as well” (P15).
In term of barriers to cross-sectoral collaboration, some
interviewees considered that there were no obstacles because
there is a common goal to be achieved. Others identified
barriers with the main ones being resources and the differences
in methods; previous studies reported the same obstacles to
integrated surveillance (20, 21, 29, 30). The following quotes
illustrate a participant’ views regarding the availability of
resources: “So the issue with speaking of companion animals
specifically, one of the major issues and barriers to collaboration
is quite bluntly funding, or the lack there of” (P17). In addition,
the lack of resources specifically for cross-sectoral collaboration
was highlighted: “We are forced to prioritise more and more; the
budget is being cut and our top priorities are not One Health.
. . . not as a priority; it is an objective, yes, but when you drill
down . . . that makes it then difficult if you haven’t got dedicated
resources” (P10). Competing priorities within organisations was
also mentioned as a factor that could impact the involvement of
some stakeholders in integrated surveillance.
Regarding the variations in the methods used, this was
considered as a technical barrier because it hinders the
comparison of data: “. . . there are still huge limitations and how
and whether we can overcome them, like standardisation of
panels for example” (P10). This variation in methodology was
considered to be due to the way the different sectors have evolved.
Need for More Cross-Sectoral
Collaboration on AMU/AMR Surveillance
Some participants regarded the current level of cross-sectoral
collaboration as adequate, whereas others mentioned a
need for improvement. This was, perhaps not surprisingly,
particularly prominent amongst interviewees who worked in
the environment sector and small animals’ sub-sector who did
not have ongoing AMR surveillance programmes and therefore
had less opportunities for collaboration. This might change
in the future especially with the increasing recognition of the
importance of having more data from these sectors. The main
areas identified by respondents as requiring improvement
include the following: (a) Methods; (b) Resources and capacity;
(c) Improved coordination of integrated surveillance activities;
(d) Surveillance data from the environment; (e) Surveillance data
from companion animals; and (f) Communication and sharing
of information.
Methods
Respondents mentioned that there is a need for improvement in
the way the data are collected and analysed to allow comparison
between the different sectors. Some interviewees called for a
standardisation of AB panels between humans and animals to be
able to compare the data; others considered that standardisation
could have a negative impact on the current system: “. . . if you
standardise, you’re forcing change on a lot of people who don’t
want change. . . So you’re forcing change on a system that has
evolved for a reason in a certain direction. It doesn’t necessarily
mean that system’s going to get better” (P16). The difficulty
to achieve harmonisation between the different methodologies
was also raised by some respondents: “. . .how do you achieve
harmonisation? Because people are very wedded to their own
systems so how do you get them to change, you know? Especially
because they’ve been collecting data for so long, they want to
do their backward comparison and so, they don’t want to move
from that position to do a sideways comparison” (P5). One of the
possibilities proposed was to start a new system as it was the
case for the EU harmonisedmonitoring programme, but then the
problem that had emerged was the fact that it was not possible to
compare with the other system in the same country. The need for
more harmonisation and integration between sectors has been
acknowledged in the UK NAP 2019–2024 (9) and respondents
explained that work was ongoing to address the commitments
from the strategy.
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Resources and Capacity
There was an overall agreement that activities are driven by
funding and several respondents commented on the need to
have funding specifically for cross-sectoral collaboration: “I also
think funding opportunities that are specifically for working across
sectors would also promote further working. You’re providing
additional resource to facilitate those cross workings, it would
be really helpful” (P18). Funding was also seen to enable some
integrated activities to be conducted more frequently. As an
example, when asked if there was a plan to produce the OH report
more frequently, P10 said: “I don’t think so, it’s very, very resource
intensive. So, the original plan was to have it biannually, that has
been obviously been delayed” (P10). The importance of having
funding dedicated specifically to cross-sectoral collaborative
activities has been described in previous studies as key for OH
initiatives to achieve their potentials (19, 29).
Improved Coordination of Integrated Surveillance
Activities
Participants highlighted the need for better coordination of
integrated surveillance for AMU/AMR with some proposing
the establishment of a coordinating committee or group. When
asked about who should oversee this coordination, respondents
mentioned the need for a group which should have three main
characteristics. Firstly, it was perceived that because it is a shared
responsibility, this group would need to have representatives
from all sectors. It was felt that if one sector takes the lead they
would push for their own priorities. Secondly, this group needs
to have the power to act: “Ultimately, it has to be somebody
in power, so I would say probably central government, and then
responsibility divested down. . . The higher up you go and the higher
up your responsibility, the more other players you’ll get involved”
(P16). Finally, this group needs to define clear set of measurable
outcomes: “I think that would be my main recommendation to
give it a proper mandate to have a committee, with clearly set
targets because even in the national strategy it is rather vague; I
think we do need measurable objectives” (P10). Some participants
proposed the use of existing group such as DARC to coordinate
this collaboration instead of creating parallel groups: “Well I, if
you really ask me then I would mandate a group like DARC to do
that, rather than creating another body,. . . it doesn’t feel right to
create a parallel committee” (P10).
Surveillance Data From the Environment
It was widely acknowledged that there was a lack of surveillance
data on AMR from the environment: “. . . it’s an area that’s
a big gap that we need to look at, the environment” (P11).
Research on environmental AMR was seen to have been mainly
done by universities, which was perceived as important but
would not replace the implementation of a statutory surveillance
programme: “Environmental AMR so far has been really an
academic or a university topic, so funded by the research councils,
and there’s still plenty of things that need researching at those
organisations or those institutions, but we also need tomove on and
do things for real, and universities cannot replace a government
surveillance or those sort of things” (P9). It was also considered
that the environment sector could learn from the experience
gained in other sectors since they had ongoing surveillance
programmes for AMR in place for a long time. In addition,
the need for funding to conduct the work was also mentioned.
Interviewees highlighted that this is an area where all sectors need
to collaborate because antibiotic usage from humans and animals
ends in the environment: “The environment goes across all sectors
and that’s one of the big areas where we should all be collaborating
on. Because whether it’s human health, companion animal or farm,
the environment is where it all ends up” (P14).
Surveillance Data From Companion Animals
Respondents highlighted the importance of continuous
monitoring of AMU and AMR from companion animals
to better understand the risk from this animal category.
Currently, antibiotic usage data from companion animals are
not systematically collected but the VMD funded studies to
investigate it and the results were included in the UK-VARSS
reports (31–33). These studies looked into AB prescriptions
using the data that were extracted from practise management
systems by VetCompass and the Small Animal Veterinary
Surveillance Network (SAVSNET) system that are managed by
the Royal Veterinary College and the University of Liverpool,
respectively. Antibiotic sales data for dogs and cats are published
in the UK-VARSS reports. Building on the success of the TTF,
RUMA announced the formation of RUMA Companion Animal
and Equine Group, which will draw from the learnings from the
TTF to develop sector specific goals to drive improvements.6
Little collaboration was reported between human sector and
companion animals’ sub-sector, which was explained by the lack
of understanding of the value of examining AMU and AMR data
in companion animals: “Very little collaboration with human side,
currently yeah. Not because we’re not interested in doing it, it’s just
because it’s not happening, and there isn’t a lot of interest coming
back. I guess the human side would have to start to understand that
there is a value in exploring usage in companion animals, and that
currently isn’t really happening” (P16). Reflecting on the fact that
there is little interest in data from companion animals compared
to food producing animals, P17 said: “. . . there’s quite a heavy
legislation surrounding food safety, therefore resistance goes higher
up the priority tree, because they’ve legislative duty or responsibility
where to ensure the food is safe. Whereas companion animals,
there isn’t really any legislative work aside from the relatively vague
animal welfare laws.”
This lack of collaboration was also seen to be due partly to the
fact that there is little awareness of the AMR risk from companion
animals and a first step would be to raise awareness on the issue:
“A lot of owners I suspect aren’t even aware that there are issues
with antimicrobial resistance in companion animals. So there’s a
huge pile of work that could be done just on raising awareness,
but that would have to come from the human side” (P16).
Respondents mentioned also the need to better understand the
different pathways of transmission of AMR between companion
animals and humans that are completely different to those
between humans and livestock: “The whole storey with humans
6https://www.ruma.org.uk/new-medicine-initiative-for-pets-and-horses-draws-
on-farm-livestock-learnings/.
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and companion animals is much more complex, because a lot
of animals will lick owner’s faces, . . . owners will hold them, they
will sleep in the bed with them. Their lives are entwined around
animals. Obviously then resistance can be passed on by multiple
different routes” (P16).
Communication and Sharing of Information
Respondents highlighted the importance of improving
collaboration by better communication and sharing of
information: “I think there’s always scope to improve collaboration,
better communication, better sharing of information, more
timely sharing of information and having reactive systems
that you don’t have to wait for the next committee, you’ve got
a mechanism to react to sudden findings of concern” (P6).
An example that was mentioned by one informant was the
importance of communication with veterinarians about some
resistance mechanisms circulating in companion animals
that are of relevance to humans: “I suppose just also sort of
better communication as well so that people are aware that
these resistance mechanisms may also be found in veterinary
samples” (P12). A wider understanding of how the different
sectors work was also seen as an important outcome for an
improved communication.
It was also highlighted that work was ongoing to explore
options to use AMR data from animals generated by private
laboratories. Currently, these data are not accessible and only
some resistance data from small animal private laboratories
are collected through the Small Animal Veterinary Surveillance
Network (SAVSNET)7. The following quote illustrate this: “The
private labs, for example, we are looking into developing that and
work more closely with the private sector and explore options to
work more with them, because obviously there are private labs that
do testing for resistance. And we know that their data is available
but currently we don’t have clear access to that data, so we are
looking into it” (P1). Increasing the availability of AMR data from
clinical samples in animals through collaboration with private
laboratories would have an impact in increasing the sensitivity
of the surveillance system to detect trends in AMR circulating at
the human-animal interface (6).
DISCUSSION
In this study, we aimed to evaluate qualitatively the performance
and value of integrated surveillance system for AMU/AMR in
England by applying the ISSE framework. The results showed
that there are links between integrated surveillance information,
decision making and intervention; especially in the case of
the Res-Alert programme. However, there were only few OH
examples where the potential of collaboration was fully exploited.
Many benefits described were related to the generation of
information and increase in knowledge and understanding
without explicit use of the information for policy or intervention
development. These intangible benefits have a value but being
able to link surveillance information and mitigation measures is
very important as it would help to enhance the value of integrated
7https://www.liverpool.ac.uk/savsnet/.
surveillance efforts. This is particularly relevant considering
budget constraints and the need to justify resource allocation to
activities. Integration and collaboration are resource consuming
and full integration in a systemmight not be necessary to achieve
the wanted outputs. Therefore, it is important to identify the
level of collaboration that will achieve the optimal performance
and cost-effectiveness (30, 34). In the following paragraphs, the
results presented in the previous section are discussed using the
levels of the ISSE framework.
OH Integration in the Surveillance System
This study showed that there were various integrated surveillance
activities for AMU and AMR with various modalities and degree
of integration and the types of outputs and outcomes depended
on the type of activity. The main integrated activities reported
that had a formal structure were the AMR contingency plan, the
UK OH reports, and the DARC group. Some of the collaborative
activities that were mentioned were informal based on the
network of contacts. Although this informal networking has a
(perceived) value, their long-term benefit is uncertain, because
collaborations may cease if the people involved move on and
there are no mechanisms to promote institutional or network
memory. Another special type of collaboration mentioned was
the TTF, an example of public-private partnership. Although the
TTF was formed mainly by stakeholders from the animal health
sector, the FSA attended as an observer and an independent
scientific group with experts from different sectors provided
advice to the group.
With regards to governance, the surveillance system for
AMU/AMR is embedded in the UK NAP for AMR and
the recommendations from the NAP are used as levers to
implement collaborative surveillance activities. The NAP is
coordinated by the HLSG but there is no committee for the
coordination of integrated surveillance activities. Respondents
commented on the need for better coordination of integrated
surveillance activities and the formation of a cross-sectoral
group to oversee this. It is important to have adequate
governance modalities for steering and coordinating integrated
surveillance to define the collaborative strategy that would
achieve the objective of this surveillance and to provide necessary
guidance and resources for its implementation (30). In addition,
this committee can also be a platform for discussions on
how to overcome the barriers to cross-sectoral collaboration
such as the difference in methods used between sectors.
Recently, a OH integrated surveillance (OHIS) sub-group of
DARC was formed with the aim to strategise the integration
of AMR surveillance across the different sectors and the
four nations8.
While there is no structured mechanism for data and
information sharing between sectors, a lot of information that
is produced is available in the public domain (e.g., the UK-
VARSS and the ESPAUR reports; and the online data portal
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transparency and presents an important source of information
for stakeholders, including policymakers, the livestock industry,
and other interested actors. There is work ongoing to explore
options for improved sharing of AMR surveillance data between
sectors in the UK such as the development of a shared database9
This would enable the collation and analysis of data to be
developed into an ongoing activity, which would improve the
timeliness of data availability and enables rapid identification
of emerging trends; therefore improving the effectiveness of
integrated surveillance (35). Furthermore, this shared database
can serve as a resource for risk assessment and generation of
evidence for policies to protect animal and human health. An
example of this is the DANMAP database which collects data
from several sources including food and hospital laboratories,
slaughter plants, veterinary practises and general practises for
people. These data are collected from various microbiological
laboratories that use different data formats and therefore these
data are imported, merged and cleaned before conducting the
data analysis (35, 36). At global level, the UK contributes to
international surveillance, which was considered by interviewees
as beneficial and adding value to the data. At local level, we
found that the first regional OH group on AMR in the UK
was successful at the beginning with various outputs produced,
which helped to facilitate discussions and enabled the sharing of
knowledge and ideas (22). However, there was limited success
for the group to maintain the work, with the main barrier
reported by interviewees being the lack of funding for these
regional groups.
There is no funding available specifically to integrated
surveillance on AMU/AMR and participants highlighted that
this constitutes a constraint to cross-sectoral collaboration.
In addition to the resources needed for sectoral surveillance,
specific resources must be allocated for activities involving
several sectors both at the governance and at operational
levels (30). Integration can take place at different steps of the
surveillance and to various extent and full integration might
not be necessary to achieve the desired outputs. Therefore, it
is important to identify the degree of collaboration that will
achieve the OH surveillance objective in a cost-effective manner
(30). This can be achieved for example by conducting economic
evaluations of different levels of surveillance integration (linked
to interventions) and assess the benefits they generate. However,
it is important to consider not only tangible benefits but also
intangible ones. Intangible benefits such as knowledge creation,
social and intellectual capital, peace of mind, political and
technical reassurance are difficult to capture through quantitative
metrics in the short term but can lead to large benefits in the
long term.
Production of OH Information and
Expertise
Various integrated surveillance activities were identified and
within these there were various OH teams working to produce
outputs. Some members were involved in multiple integrated
9https://www.food.gov.uk/news-alerts/news/ps192-million-for-cross-
government-surveillance-project-to-protect-public-health.
activities but others were involved only in one. For example,
the OH team producing the UK OH reports was formed
by representatives from the different sectors that had good
working relationship and worked well as a team based on
the comments from interviewees. Similarly, the OH team of
the DARC group was considered as a good team with the
right people in it. For the AMR contingency plan, members
who are managing the alert system are the same but other
members change based on the hazard identified. Regarding
the OH network, surveillance data produced are publically
available so can reach a wide range of stakeholders. In term
of the quality of OH information produced, the current
surveillance system includes data from humans, animals and
food, but does not include data from the environment.
However, work is ongoing to include data from this sector
(9). Respondents highlighted also the power of this collective
data in providing a stronger message and sounder evidence.
The importance of information generated by OH surveillance
activities to better inform discussions in terms of risk assessment
and management in the case of zoonosis disease has been
described previously (34).
There is also ongoing work to strengthen sectoral surveillance
components by collecting AB usage data from species that are not
covered and by increasing coverage in species with low coverage;
and by exploring options to include AMR data in animals
from private laboratories. Strengthening sectoral surveillance
components will have an impact on improving the outputs and
outcomes of integrated surveillance (2, 4).
Generation of Actionable Knowledge and
Influence on Decision Making
The outcomes of integrated surveillance activities varied
depending on the type of the activity. For example the AMR
contingency plan was considered by respondents as an action
oriented activity allowing to detect emerging resistances. It
was clear from participants’ views and examples provided that
the information and evidence generated by this integrated
activity was shared with relevant stakeholders and was used
to make relevant decisions at policy level for interventions
to be implemented. This was a direct example of how OH
information produced impacted on decision making. For the UK
OH reports, however, the main outcomes were about improving
integrated analysis and harmonising the data across sectors,
which in turn help to better understand the epidemiology of
AMR and detect AMR trends at the human-animal interface.
These reports are publically available and are valuable sources
of information that can be used by stakeholders for a better
understanding of cross-sectoral issues on AMR. However,
it was not possible to evaluate the impacts of this OH
information produced.
Regarding the DARC group, the main outcomes were
related to communication and exchange of information
and expertise, which leads to an increase in awareness and
understanding of the AMR issue and its wider impacts. In
addition, cross-sectoral communication was considered key
in understanding other sectors’ priorities and challenges and
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enabling discussions to reach agreeable decisions. Another
positive outcome was the establishment of good working
relationships across sectors and relationships that could be
used for further collaborative work. The improvement of
knowledge and understanding and generation of social and
intellectual capital have been identified as benefits of OH
approaches in reviewed literature (37). These intangible
benefits should be considered in evaluation in addition
to monetary outcomes although its quantification is not
always possible (2, 34).
Contribution to Desirable Outcomes
There has been a decrease in AB sales in food-producing
animals in the UK in the past years, which made the UK
one of the lowest users of antibiotics across Europe (27, 38).
This decrease was mainly due to the work of the RUMA TTF,
farmers and the different stewardship programmes developed
by the different livestock sectors (25, 27). Following this, a
decrease in the levels of resistance in E. coli isolates from
broilers examined at slaughter was observed for most antibiotics
tested (16). Also, resistance in in E. coli from healthy pigs
at slaughter was reported at lower levels compared to five
years ago (27). These data show real progress and possible
impact of the reduction of AMU in animals but long-term
monitoring is needed to be able to fully assess these links,
especially that it can be challenging to differentiate between the
benefits of cross-sectoral collaboration and the wider benefits
of surveillance.
In terms of improvement, the main areas mentioned
were the development of more harmonised methods for data
collection and analysis across sectors, better coordination of
integrated surveillance, having resources dedicated to cross-
sectoral collaboration, and collection of surveillance data from
the environment and from companion animals. The use of
comparable methods is necessary to allow comparison of results
not only within the country but also within region and at
global level. The guidance developed by WHO states that a
programme of integrated surveillance of AMR in foodborne
bacteria needs to include coordinated sampling and testing
of antimicrobial susceptibility of bacteria from food-producing
animals, food and humans using epidemiological (including
sampling) and microbiological methods that enable comparisons
of results (39).With regards to surveillance data from companion
animals, there is a need for continuous monitoring of AMU
and AMR from this category to better understand the risk
that they pose. Although the quantity of antibiotic use in
this category is low compared to other farm animals, there
is a high risk due to their close interactions with humans.
However, there is little awareness of this risk and participants
highlighted the importance to increase awareness about this
issue. On the environmental side, respondents highlighted the
huge data gap and the need for greater integration. The
knowledge and evidence gap of AMR in the environment
has been increasingly recognised (40, 41) and one of the of
the priorities in the new NAP is to better understand the
role of the environment in the spread of AMR (9). The
implementation of changes in such a complex system can
be challenging especially that surveillance is expensive and
appropriate resources need to be allocated to integrated activities.
However, having a NAP which includes commitments to develop
a more harmonised and integrated surveillance for AMU/AMR
can help in directing the necessary resources and capacity to
achieve the goals set.
An important dimension linked to integrated surveillance
that was identified in this study is cross-sectoral collaborative
research, with several examples of activities involving different
sectors. Research was considered to underpin surveillance work
and targeted research works fill the gap in knowledge and
allow the development of new methods that could be used
in surveillance. Hence, it is important to assess the capacity
of the surveillance system to facilitate research work and
this is another dimension that could be added to the ISSE
framework. Another dimension that could be added to this
framework relates to the collaboration at international level.
The importance of collective data was highlighted by many
participants and it is important to assess this explicitly when
conducting the evaluation.
Several of the benefits described by participants were
intangible such as enhanced knowledge and understanding,
and social capital. Future studies should aim to capture
these benefits explicitly. Moreover, the associations between
outputs and outcomes were not always clear. Several
integrated activities were described with some producing
OH information which impacted on decision making, while
others producing outcomes related mainly to the generation of
information and increase in knowledge without links to how
the information generated is used. With firm links between
surveillance information and mitigation measures with clear
attribution, this would allow estimating the value of integrated
surveillance efforts with more accuracy. In addition, this
would enable to better recognise the benefits of cross-sectoral
collaboration, as it is currently challenging to differentiate
between the wider benefits of surveillance and the benefits
of collaboration.
The ISSE framework used is new and this study was
one of its first applications. This framework was a useful
foundation to structure the evaluation of different outcomes in
the case of integrated surveillance for AMU/AMR. However,
the framework does not provide guidance on how to conduct
the evaluation, which data to collect and how to analyse
them; this needs to be elaborated by the evaluator(s). It
is comprehensive and encourages consideration of a broad
range of elements and change pathway. When considering all
five evaluation levels, as done in this study, a lot of data
and time are required to do the evaluation. Resources can
potentially be saved if users focus only on one or two levels
depending on their needs and context. This framework can
also be used in combination with other tools such as NEOH
and ECoSur.
Purposive sampling is widely used in qualitative research
to select information-rich cases related to the phenomenon
of interest (42). In this study, purposeful sampling was used
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to identify stakeholders who have knowledge, experience and
involvement in the surveillance system for AMU/AMR in
England covering human, animal, food and environmental
sectors; which allowed to include diverse viewpoints. Although
we covered key stakeholders involved, not all groups were
included such as practitioners, representatives from relevant
industries and Non-Governmental Organisations. Purposively
selected samples are of benefit for qualitative research as it allows
the collection of rich, in depth account from participants.
This evaluation allowed to identify effective and ineffective
points in the surveillance system for AMU/AMR in England.
The effective points include: (1) the presence of a National
Action Plan based on a OH approach with commitments
to strengthen integrated surveillance for AMU/AMR; (2) the
presence of a cross-sectoral alert system which allows a OH
response in the case of identification of resistance bacteria
or genes posing high risk; (3) the presence of cross-sectoral
working groups; (4) publication of surveillance data in reports
that are publically available; and (5) production of OH joint
reports that are publically available. These activities demonstrate
a commitment to One Health in AMU and AMR surveillance
and lead to positive outcomes such as the provision of enhanced
information for decision making, improved communication,
exchange of information and expertise, and increase of awareness
and understanding. Inefficiencies in the system identified were
the absence of a steering and coordinating committee to
oversee integrated surveillance activities; the lack of resources
dedicated specifically to integrated surveillance activities for
AMU/AMR; and the variations in the methods used between
sectors. This evaluation showed also that the surveillance
system in England is evolving with various initiatives recently
implemented or under development. Examples of these activities
include the formation of a OH integrated surveillance sub-
group of DARC, collection of AB usage data from companion
animals, collection of AMR data from the environment and
from private laboratories, and the development of a database to
share AMR data across sectors. These initiatives aim to enhance
the availability of AMU and AMR data, and improve data
sharing and collaboration. This indicates that the stakeholders are
implementing changes andmaking investments in OH to address
the needs identified. It is expected that with additional data
becoming available, more evidence will be generated which will
enhance the understanding of the epidemiology of AMR at the
human-animal-environmental interface; and therefore inform
the implementation of evidence based integrated surveillance
activities on AMU/AMR. However, it is important to have
regular evaluation to ensure that the surveillance programmes are
operational and effective.
This study allowed an understanding of the capacity of
the system to produce OH surveillance information and the
links between this OH information produced and the various
outputs and outcomes. Based on this evaluation, we propose the
following indicators that can be used for the assessment of the
performance of integrated surveillance system for AMU/AMR.
These are: (i) the capacity of the system to produce OH
information; (ii) the capacity of the system to use the OH
information generated to enhance the knowledge and inform the
implementation of interventions; and (iii) the capacity of the
system to provide a OH response in the case of identification
of resistance bacteria or genes posing a high risk to human or
animal health. Future work on surveillance evaluation should
consider ways of measuring these three indicators. The lack
of knowledge on the most effective and efficient integrated
surveillance strategies for AMU/AMR makes the development
of benchmarks and best practises challenging. Research on how
the different levels of integration influence the performances of
integrated surveillance systems for AMU/AMR would allow to
generate the evidence needed for recommending best practises.
This study contributed to this knowledge and more will be
learned once other integrated surveillance systems are evaluated
and more evidence is generated.
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